S, K., H, H., Y, T., & T, T. (2024). Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD-Authors' reply. Alimentary pharmacology & therapeutics, 60(6), 827. https://doi.org/10.1111/apt.18186
Chicago Style (17th ed.) CitationS, Kumazaki, Hikita H, Tahata Y, and Takehara T. "Letter: Association of Serum Growth Differentiation Factor 15 and Liver-related Outcomes in Patients with MASLD-Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 6 (2024): 827. https://doi.org/10.1111/apt.18186.
MLA (9th ed.) CitationS, Kumazaki, et al. "Letter: Association of Serum Growth Differentiation Factor 15 and Liver-related Outcomes in Patients with MASLD-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 6, 2024, p. 827, https://doi.org/10.1111/apt.18186.